These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24219216)

  • 1. Sundowning syndrome and hypothalamic-pituitary-adrenal axis dysregulation in individuals with Alzheimer's disease: is there an association?
    Venturelli M; Scarsini R; Muti E; Salvagno GL; Schena F
    J Am Geriatr Soc; 2013 Nov; 61(11):2055-6. PubMed ID: 24219216
    [No Abstract]   [Full Text] [Related]  

  • 2. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease.
    Swanwick GR; Coen RF; Walsh JB; Coakley D; Lawlor BA
    Biol Psychiatry; 1996 Jun; 39(11):976-8. PubMed ID: 9162211
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of circadian rhythms and hypothalamic-pituitary-adrenal axis: an overlooked interaction in cancer.
    Innominato PF; Palesh O; Dhabhar FS; Lévi F; Spiegel D
    Lancet Oncol; 2010 Sep; 11(9):816-7. PubMed ID: 20816374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased activity of stress-regulating systems in Alzheimer disease].
    Hoogendijk WJ; Meynen G; Feenstra MG; Eikelenboom P; Kamphorst W; Swaab DF
    Tijdschr Gerontol Geriatr; 2001 Feb; 32(1):17-23. PubMed ID: 11293840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Hypothalamic-Pituitary-Adrenal Axis, Hypothalamic-Pituitary-Gonadal Axis and Insulin Signaling in the Pathophysiology of Alzheimer's Disease.
    Ahmad MH; Fatima M; Mondal AC
    Neuropsychobiology; 2019; 77(4):197-205. PubMed ID: 30605907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings.
    Swanwick GR; Kirby M; Bruce I; Buggy F; Coen RF; Coakley D; Lawlor BA
    Am J Psychiatry; 1998 Feb; 155(2):286-9. PubMed ID: 9464214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling sundowning in a patient with Alzheimer's disease.
    Sharer J
    Medsurg Nurs; 2008 Feb; 17(1):27-9. PubMed ID: 18429537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease.
    Woods DL; Dimond M
    Biol Res Nurs; 2002 Oct; 4(2):104-14. PubMed ID: 12408216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease.
    Satlin A; Volicer L; Ross V; Herz L; Campbell S
    Am J Psychiatry; 1992 Aug; 149(8):1028-32. PubMed ID: 1353313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease.
    Martin J; Marler M; Shochat T; Ancoli-Israel S
    Chronobiol Int; 2000 May; 17(3):405-18. PubMed ID: 10841213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol and wake time in nursing home residents with behavioral symptoms of dementia.
    Woods DL; Martin JL
    Biol Res Nurs; 2007 Jul; 9(1):21-9. PubMed ID: 17601854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain imaging: neuropathologic applications to Alzheimer's disease: role of tomodensitometry and endocrine evaluation].
    Leonardi M; Martelli A; Costa A; Mauri M; Zanotti B; Zappoli F
    Bull Assoc Anat (Nancy); 1991 Jun; 75(229):97-9. PubMed ID: 1777726
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity--a dynamic digital-to-analog modulation.
    Chrousos GP
    Endocrinology; 1998 Feb; 139(2):437-40. PubMed ID: 9449607
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
    Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
    Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the hypothalamic-pituitary-adrenocortical axis in chronic leukaemia.
    Migdalska B; Leszko B; Hartwig W; Pawelski S
    Haematologia (Budap); 1976; 10(2):235-42. PubMed ID: 1071742
    [No Abstract]   [Full Text] [Related]  

  • 16. Sundowning in the Alzheimer's patient.
    Carson VB
    Caring; 2012 Jun; 31(6):52-3. PubMed ID: 22953389
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF; Kühnhardt D; Bartholomae A; Pfeiffer S; Schmid P; Possinger K; Flath BC; Lüftner D
    Integr Cancer Ther; 2010 Sep; 9(3):270-5. PubMed ID: 20702499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender.
    Peskind ER; Raskind MA; Wingerson D; Pascualy M; Thal LJ; Dobie DJ; Wilkinson CW
    Biol Psychiatry; 1996 Jul; 40(1):61-8. PubMed ID: 8780856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis dysfunction during sleep in nocturnal asthma.
    Sutherland ER; Kraft M; Rex MD; Ellison MC; Martin RJ
    Chest; 2003 Mar; 123(3 Suppl):405S. PubMed ID: 12629004
    [No Abstract]   [Full Text] [Related]  

  • 20. Sundowning and circadian rhythms in Alzheimer's disease.
    Volicer L; Harper DG; Manning BC; Goldstein R; Satlin A
    Am J Psychiatry; 2001 May; 158(5):704-11. PubMed ID: 11329390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.